Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)
| Jurisdiction: | Federal |
| Incentive Type: | Grant Program |
| Industries: | Medical |
| Eligible Sector: | Business |
| Category: | Financial Incentive |
| Time Period: | FY 2015 |
| Governing Body: | National Institutes of Health |
| What’s it worth?: | Not mentioned |
A Small Business Innovation Technology Transfer Research (STTR) grant opportunity (PA-13-140) for small business concerns (SBCs), with no more than 500 employees, to develop tools that will advance the understanding of the cellular basis of disease.
Maximum funding is generally $150,000 for Phase 1 of the research project and $1,000,000 for Phase 2, with the potential for 50% more (up to $225,000 in Phase 1 and $1,500,000 in Phase 2) or even higher if the additional funding is determined to be justified or necessary. Full application directions for SG424 (R&R) are available at Grants.gov.
